Consorci Sanitari Integral
- Address
- Dos De Maig 301, 08025 Barcelona, Spain
Eye Diseases
The research at Consorci Sanitari Integral concentrates on retinal disorders, testing innovative therapies to preserve vision and reduce disease progression.
- Diabetic Macular Edema
- Geographic Atrophy
- Neovascular age‑related macular degeneration
Ongoing studies evaluate suprachoroidal OXU-001, gene‑based injections, and a port delivery system with ranibizumab, all aimed at improving visual acuity and patient outcomes.
Pathological Conditions, Signs and Symptoms
This therapeutic area links systemic disease manifestations with ocular health, focusing on conditions that present both renal and visual signs.
- IgA Nephropathy
- proteinuria reduction
- atacicept
The atacicept trial investigates immune modulation to lower renal protein loss while monitoring ocular safety, reflecting the interdisciplinary approach of the Barcelona site.
Ocular Physiological Phenomena
Research explores fundamental retinal mechanisms, seeking to interrupt pathological processes through novel delivery strategies.
- suprachoroidal drug delivery
- gene therapy vectors
- OCS‑01 eye drops
By assessing physiological responses, the center evaluates long‑acting treatments such as OCS‑01 eye drops and AAV‑based therapies, aiming to enhance patient convenience and adherence.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Consorci Sanitari Integral
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) | Janssen Cilag International | Phase II | Not Recruiting | Aug 2023 | Feb 2026 |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dexamethasone | 2 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.